High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization

被引:114
作者
Zhang, XX
Snijders, A
Segraves, R
Zhang, XQ
Niebuhr, A
Albertson, D
Yang, HM
Gray, J
Niebuhr, E
Bolund, L
Pinkel, D
机构
[1] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
[4] Univ Aarhus, Inst Human Genet, Aarhus, Denmark
[5] Univ Copenhagen, Inst Med Biochem & Genet, Copenhagen, Denmark
[6] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China
关键词
D O I
10.1086/427762
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have used array comparative genomic hybridization to map DNA copy-number changes in 94 patients with cri du chat syndrome who had been carefully evaluated for the presence of the characteristic cry, speech delay, facial dysmorphology, and level of mental retardation (MR). Most subjects had simple deletions involving 5p (67 terminal and 12 interstitial). Genotype-phenotype correlations localized the region associated with the cry to 1.5 Mb in distal 5p15.31, between bacterial artificial chromosomes (BACs) containing markers D5S2054 and D5S676; speech delay to 3.2 Mb in 5p15.32-15.33, between BACs containing D5S417 and D5S635; and the region associated with facial dysmorphology to 2.4 Mb in 5p15.2-15.31, between BACs containing D5S208 and D5S2887. These results overlap and refine those reported in previous publications. MR depended approximately on the 5p deletion size and location, but there were many cases in which the retardation was disproportionately severe, given the 5p deletion. All 15 of these cases, approximately two-thirds of the severely retarded patients, were found to have copy-number aberrations in addition to the 5p deletion. Restriction of consideration to patients with only 5p deletions clarified the effect of such deletions and suggested the presence of three regions, MRI-III, with differing effect on retardation. Deletions including MRI, a 1.2-Mb region overlapping the previously defined cri du chat critical region but not including MRII and MRIII, produced a moderate level of retardation. Deletions restricted to MRII, located just proximal to MRI, produced a milder level of retardation, whereas deletions restricted to the still-more proximal MRIII produced no discernible phenotype. However, MR increased as deletions that included MRI extended progressively into MRII and MRIII, and MR became profound when all three regions were deleted.
引用
收藏
页码:312 / 326
页数:15
相关论文
共 36 条
[1]   Genomic microarrays in human genetic disease and cancer [J].
Albertson, DG ;
Pinkel, D .
HUMAN MOLECULAR GENETICS, 2003, 12 :R145-R152
[2]   Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene [J].
Albertson, DG ;
Ylstra, B ;
Segraves, R ;
Collins, C ;
Dairkee, SH ;
Kowbel, D ;
Kuo, WL ;
Gray, JW ;
Pinkel, D .
NATURE GENETICS, 2000, 25 (02) :144-146
[3]   High-resolution physical and transcript map of the Cri du chat region of human chromosome 5p [J].
Church, DM ;
Yang, J ;
Bocian, M ;
Shiang, R ;
Wasmuth, JJ .
GENOME RESEARCH, 1997, 7 (08) :787-801
[4]  
CHURCH DM, 1995, AM J HUM GENET, V56, P1162
[5]   Recent duplication, domain accretion and the dynamic mutation of the human genome [J].
Eichler, EE .
TRENDS IN GENETICS, 2001, 17 (11) :661-669
[6]   DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones [J].
Fiegler, H ;
Carr, P ;
Douglas, EJ ;
Burford, DC ;
Hunt, S ;
Smith, J ;
Vetrie, D ;
Gorman, P ;
Tomlinson, IPM ;
Carter, NP .
GENES CHROMOSOMES & CANCER, 2003, 36 (04) :361-374
[7]   Development of diagnostic tools for the analysis of 5p deletions using interphase FISH [J].
Gersh, M ;
Grady, D ;
Rojas, K ;
Lovett, M ;
Moyzis, R ;
Overhauser, J .
CYTOGENETICS AND CELL GENETICS, 1997, 77 (3-4) :246-251
[8]  
GERSH M, 1995, AM J HUM GENET, V56, P1404
[9]  
Hand JL, 2000, PRENATAL DIAG, V20, P144, DOI 10.1002/(SICI)1097-0223(200002)20:2<144::AID-PD770>3.0.CO
[10]  
2-9